Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 30.6% | 30.8% | 29.2% | 39.4% | 51.7% | 38.1% | 34.5% | 16.4% |
Gross profit | 69.4% | 69.2% | 70.8% | 60.6% | 48.3% | 61.9% | 65.5% | 83.6% |
Selling, general and administrative | 108.1% | 168.9% | 13.8% | 85.4% | 22.9% | 57.8% | 36.6% | 45.7% |
Research and development | | | | | | 1.2% | 1.5% | 3.0% |
General and administrative | | | | | | | | |
EBITDA | -38.4% | -99.1% | -44.2% | -24.5% | -39.8% | 3.3% | 26.2% | 32.7% |
Depreciation | 0.3% | 0.5% | 0.2% | 0.3% | 0.8% | 0.5% | 0.2% | 0.2% |
EBITA | -38.7% | -99.6% | -44.4% | -24.8% | -40.6% | 2.7% | 26.1% | 32.5% |
Amortization of intangibles | | | | | | 4.7% | 3.6% | 3.5% |
EBIT | -38.7% | -99.6% | -44.4% | -24.8% | -40.6% | -1.6% | 23.8% | 29.0% |
Pre-tax income | -52.6% | -120.1% | -80.3% | -40.3% | -54.7% | -2.9% | 21.3% | 37.0% |
Income taxes | 0.3% | 0.3% | 4.0% | -11.3% | -24.5% | -0.6% | 7.6% | 4.5% |
Net income | 0.0% | 0.0% | 0.0% | -29.0% | -33.7% | -2.3% | 13.8% | 28.0% |
|